Neuro-Oncology Reviews
Volume
26 Number 25
10 November 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 25, 10 November
Ghasemi E, Mondanizadeh M, Almasi-Hashiani A, Mahboobi E.
The
significance of miR-124 in the diagnosis and prognosis of glioma:
A systematic review.
PLoS
One. 2024 Nov 1;19(11):e0312250. doi:
10.1371/journal.pone.0312250. PMID:
39485747. Review. ˍ
Satish S, Athavale M, Kharkar PS.
Targeted
therapies for Glioblastoma multiforme (GBM): State-of-the-art and
future prospects.
Drug
Dev Res. 2024 Nov 1;85(7):e22261. doi:
10.1002/ddr.22261. PMID:
39485272. Review˰ ˍ
Beylerli O, Gareev I, Ilyasova T, Musaev E, Chekhonin V.
The
Mechanism of Action of Exosomes Derived from Glioblastoma Cells.
Curr
Med Chem. 2024 Nov 4. doi:
10.2174/0109298673344390241017065119. PMID:
39501957. Review˰ ˍ
Grabenweger R, Völz D, Weck C, Hau P, Paal P, Bumes E.
Spirituality in Professional
Patient-Centered Care for Adults with Primary Brain Tumors: An
Exploratory Scoping Review.
J
Relig Health. 2024 Nov 5. doi:
10.1007/s10943-024-02161-x. PMID:
39500854. Review. ˍ
Ritchey
AK
et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma: Patient
Version.
PDQ
Cancer Inf Summ.
2024
Nov
5. NCBI Bookshelf ID:
NBK65742.
PMID:
26389185.
Review
Malone K, LaCasse E, Beug ST.
Cell
death in glioblastoma and the central nervous system.
Cell
Oncol (Dordr). 2024 Nov 6. doi:
10.1007/s13402-024-01007-8. PMID:
39503973. Review. ˍ
Wen PY.
Progress in treatment of
gliomas.
Curr
Opin Neurol. 2024 Nov 7;37(6):655-656. doi:
10.1097/WCO.0000000000001324. PMID:
39498845. Editorial. ˍ